Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
D274696-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $325.90 | |
D274696-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $586.90 |
Selective group I mGlu agonist
Synonyms | (2r)-Amino(3,5-Dihydroxyphenyl)Acetic Acid | (S)-3,5-DHPG | HMS3411L21 | (S)-3,5-Dihydroxyphenylglycine hydrate | HB0045 | NCGC00024800-01 | NCGC00024800-04 | BDBM50079183 | J516.528H | NCGC00015338-02 | (S)-3,5-Dihydroxyphenylglycine | EN300-3004820 | Q2 |
---|---|
Specifications & Purity | ≥99% |
Biochemical and Physiological Mechanisms | Selective group I mGlu agonist. Also available in simple stock solutions - add 1 ml of water to get an exact, ready-to-use concentration. |
Storage Temp | Protected from light,Store at -20°C,Desiccated |
Shipped In | Ice chest + Ice pads |
Note | This compound is also unstable in alkaline solution when it rapidly forms a brown colouration it is therefore recommended that alkaline is not used to dissolve this compound. We recommend stock solutions are made up in water, aliquoted immediately and stored at -20°C. They should be used within one week. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | Store at -20°C. Store In the Dark. Store under desiccating conditions. This product is air and light sensitive and impurities can occur as a result of air oxidation or due to metabolism by microbes. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | (2S)-2-amino-2-(3,5-dihydroxyphenyl)acetic acid |
---|---|
INCHI | InChI=1S/C8H9NO4/c9-7(8(12)13)4-1-5(10)3-6(11)2-4/h1-3,7,10-11H,9H2,(H,12,13)/t7-/m0/s1 |
InChi Key | HOOWCUZPEFNHDT-ZETCQYMHSA-N |
Canonical SMILES | C1=C(C=C(C=C1O)O)C(C(=O)O)N |
Isomeric SMILES | C1=C(C=C(C=C1O)O)[C@@H](C(=O)O)N |
PubChem CID | 443586 |
Molecular Weight | 183.16 |
Enter Lot Number to search for COA:
Solubility | Soluble in water to 50 mM |
---|---|
Sensitivity | air and light sensitive |
1. Cho HP, Garcia-Barrantes PM, Brogan JT, Hopkins CR, Niswender CM, Rodriguez AL, Venable DF, Morrison RD, Bubser M, Daniels JS et al.. (2014) Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics.. ACS Chem Biol, 9 (10): (2334-46). [PMID:25137254] [10.1021/op500134e] |
2. Noetzel MJ, Rook JM, Vinson PN, Cho HP, Days E, Zhou Y, Rodriguez AL, Lavreysen H, Stauffer SR, Niswender CM et al.. (2012) Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function.. Mol Pharmacol, 81 (2): (120-33). [PMID:22021324] [10.1021/op500134e] |
3. Redolfi N et al.. (2021) A New Transgenic Mouse Line for Imaging Mitochondrial Calcium Signals.. Function (Oxf), 2 (3): (zqab012). [PMID:35330679] |
4. Topolnik L et al.. (2009) Activity-dependent compartmentalized regulation of dendritic Ca2+ signaling in hippocampal interneurons.. J Neurosci, 29 (14): (4658-63). [PMID:19357290] |
5. Aloisi E et al.. (2017) Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice.. Nat Commun, 8 (1103). [PMID:29062097] |
6. Bridges TM et al.. (2013) Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanism.. Drug Metab Dispos, 41 (9): (1703-14). [PMID:23821185] |
7. Serra I et al.. (2022) Ca2+-modulated photoactivatable imaging reveals neuron-astrocyte glutamatergic circuitries within the nucleus accumbens.. Nat Commun, 13 (5272). [PMID:36071061] |
8. Fernandes G et al.. (2021) Correction of amygdalar dysfunction in a rat model of fragile X syndrome.. Cell Rep, 37 (2): (109805). [PMID:34644573] |
9. Kalmbach BE et al.. (2013) Dendritic generation of mGluR-mediated slow afterdepolarization in layer 5 neurons of prefrontal cortex.. J Neurosci, 33 (33): (13518-32). [PMID:23946410] |
10. Shin JH et al.. (2009) Depolarization-induced slow current in cerebellar Purkinje cells does not require metabotropic glutamate receptor 1.. Neuroscience, 162 (3): (688-93). [PMID:19409231] |
11. Bragina L et al.. (2015) Differential expression of metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals.. Front Cell Neurosci, 9 (345). [PMID:26388733] |
12. Li Y et al.. (2012) Epileptic stimulus increases Homer 1a expression to modulate endocannabinoid signaling in cultured hippocampal neurons.. Neuropharmacology, 63 (6): (1140-9). [PMID:22814532] |
13. Niculescu D et al.. (2013) Erg potassium currents of neonatal mouse Purkinje cells exhibit fast gating kinetics and are inhibited by mGluR1 activation.. J Neurosci, 33 (42): (16729-40). [PMID:24133274] |
14. Chanda S & Xu-Friedman MA. (2011) Excitatory modulation in the cochlear nucleus through group I metabotropic glutamate receptor activation.. J Neurosci, 31 (20): (7450-5). [PMID:21593328] |
15. Špirková A et al.. (2022) Glutamate can act as a signaling molecule in mouse preimplantation embryos†.. Biol Reprod, 107 (4): (916-927). [PMID:35746896] |
16. Roloff AM et al.. (2010) Homer 1a gates the induction mechanism for endocannabinoid-mediated synaptic plasticity.. J Neurosci, 30 (8): (3072-81). [PMID:20181604] |
17. Li DP & Pan HL. (2010) Increased group I metabotropic glutamate receptor activity in paraventricular nucleus supports elevated sympathetic vasomotor tone in hypertension.. Am J Physiol Regul Integr Comp Physiol, 299 (2): (R552-61). [PMID:20519363] |
18. Gan J et al.. (2011) Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase-activated receptor-2.. Br J Pharmacol, 163 (5): (984-94). [PMID:21366553] |
19. Colavita M et al.. (2016) Layer-specific potentiation of network GABAergic inhibition in the CA1 area of the hippocampus.. Sci Rep, 6 (28454). [PMID:27345695] |
20. Trovò L et al.. (2013) Low hippocampal PI(4,5)P2 contributes to reduced cognition in old mice as a result of loss of MARCKS.. Nat Neurosci, 16 (4): (449-55). [PMID:23434911] |
21. Cosgrove KE & Maccaferri G. (2012) mGlu1a-dependent recruitment of excitatory GABAergic input to neocortical Cajal-Retzius cells.. Neuropharmacology, 63 (3): (486-93). [PMID:22579657] |
22. Wagner W et al.. (2019) Myosin VI Drives Clathrin-Mediated AMPA Receptor Endocytosis to Facilitate Cerebellar Long-Term Depression.. Cell Rep, 28 (11-20.e9). [PMID:31269433] |
23. Quattrocolo G & Maccaferri G. (2013) Novel GABAergic circuits mediating excitation/inhibition of Cajal-Retzius cells in the developing hippocampus.. J Neurosci, 33 (13): (5486-98). [PMID:23536064] |
24. Lafourcade CA et al.. (2009) Novel mGluR- and CB1R-independent suppression of GABA release caused by a contaminant of the group I metabotropic glutamate receptor agonist, DHPG.. PLoS One, 4 (7): (e6122). [PMID:19568435] |
25. Kovacs FE et al.. (2011) Purine receptor-mediated endocannabinoid production and retrograde synaptic signalling in the cerebellar cortex.. Br J Pharmacol, 162 (4): (974-88). [PMID:21054344] |
26. Subrahmanyam R et al.. (2021) Reciprocal regulation of spontaneous synaptic vesicle fusion by Fragile X mental retardation protein and group I metabotropic glutamate receptors.. J Neurochem, 158 (5): (1094-1109). [PMID:34327719] |
27. Asiedu MN et al.. (2011) Spinal protein kinase M ? underlies the maintenance mechanism of persistent nociceptive sensitization.. J Neurosci, 31 (18): (6646-53). [PMID:21543593] |
28. Cassé F & Martin S. (2015) Tracking the activity-dependent diffusion of synaptic proteins using restricted photoconversion of Dendra2.. Front Cell Neurosci, 9 (367). [PMID:26441538] |